COMP <GO>
HALO vs BNTX // 10Y YIELD & FRED MACRO BETA
Halozyme Therapeutics Inc. (NASDAQ) VS. BioNTech SE (NASDAQ) • 15-METRIC TALLY: HALO 7
— BNTX 5
▲ 10Y YIELD & FRED MACRO BETA LEADER: BNTX
LAST: $130.91 (-0.21%) • MKT CAP: $14.89B
macro-sensitivity
0.88
LAST: $88.17 (-1.08%) • MKT CAP: $22.39B
macro-sensitivity
1.02
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HALO VS. BNTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HALO | BNTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 83.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 9.90% | +8.10 | HALO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 35.6x | 21.0x | +14.60 | BNTX | /valuation <GO> |
| Free Cash Flow Yield | 4.33% | 2.21% | +2.12 | HALO | /fcf-yield <GO> |
| Operating Margin | 33.60% | 13.90% | +19.70 | HALO | /operating-margins <GO> |
| Net Profit Margin | 22.70% | 10.90% | +11.80 | HALO | /net-margins <GO> |
| Revenue Growth (YoY) | 37.60% | 14.30% | +23.30 | HALO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.11 | 3.74 | +1.37 | HALO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | BNTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 79.0 | 43.4 | +35.60 | HALO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.88 | 1.02 | -0.14 | BNTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.5x | 27.6x | +11.90 | BNTX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.89B | $22.39B | -$7.50B | BNTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HALO REV | BNTX REV | HALO GROSS % | BNTX GROSS % | HALO FCF | BNTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.40B | — | 83.6% | — | $644.6M | — |
| FY 2024 | $1.02B | — | 84.3% | — | $468.4M | — |
| FY 2023 | $829.3M | — | — | — | $351.3M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HALO // BETA 0.88
BNTX // BETA 1.02